Erick Turner's guest appearances

Erick Turner

Mad in America: Rethinking Mental Health

Plenary Session

Mark Lewis

John McConnell

Carl Hart

Marty Makary

Adam Cifu

Vinay Prasad

Jenny Gill

Tom DeLoughery

Dan Morgan

John Ioannidis

David Carr

Ameet Sarpatwari

Matthew Smith

Brian Chan

Raj Chetty

OwlTail

Erick Turner is an Associate Professor in the Department of Psychiatry at the Oregon Health and Science University (OHSU). He is also a senior scholar with OHSU’s Center for Ethics and Health Care. Dr. Turner has been an FDA reviewer and has dedicated his work and life to improving research transparency. He’s well known for his work on publication bias and antidepressant trials, but his findings show that psychotherapy research is also riddled with problems. What happens when those we trust with knowledge in our society betray us? In today’s interview, we discuss how dubious research practices are not simply the work of a few bad apples but instead built into the way we produce knowledge. We further explore the consequences of these practices on patients and the dangerous tradition of journal worship before exploring how many of these problems can be solved. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. To find the Mad in America podcast on your preferred podcast player, click here

Erick Turner is an Associate Professor in the Department of Psychiatry at the Oregon Health and Science University (OHSU). He is also a senior scholar with OHSU’s Center for Ethics and Health Care. Dr. Turner has been an FDA reviewer and has dedicated his work and life to improving research transparency. He’s well known for his work on publication bias and antidepressant trials, but his findings show that psychotherapy research is also riddled with problems. What happens when those we trust with knowledge in our society betray us? In today’s interview, we discuss how dubious research practices are not simply the work of a few bad apples but instead built into the way we produce knowledge. We further explore the consequences of these practices on patients and the dangerous tradition of journal worship before exploring how many of these problems can be solved. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, <a href="https://www.madinamerica.com/donate/" rel="noopener nofollow" target="_blank">please help us</a> continue to survive and grow. To find the Mad in America podcast on your preferred podcast player, <a href="https://pod.link/1212789850" rel="noopener nofollow" target="_blank">click here</a>

Erick Turner - Making a Silk Purse Out of a Sow's Ear: How Publication Bias Threatens Research Integrity and Public Health

In this episode, we tackle the recent papers in the New England Journal of Medicine on "Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma" and "Immunotherapy Combinations in Multiple Myeloma", as well as a comment in The Lancet Oncology's editorial "9 Weeks That Matter for Patients With Gastric Cancer". We conclude with an interview with Dr. Erick Turner of OHSU on the FDA, regulatory capture, selective reporting, and transparency.Elo-pom-dex: http://doi.org/10.1056/NEJMoa1805762Immunotherapy combinations: http://doi.org/10.1056/NEJMp18036029 weeks that matter: http://doi.org/10.1016/S1470-2045(18)30752-6Dr. Turner's seminal paper: https://doi.org/10.1056/NEJMsa065779

In this episode, we tackle the recent papers in the New England Journal of Medicine on "Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma" and "Immunotherapy Combinations in Multiple Myeloma", as well as a comment in The Lancet Oncology's editorial "9 Weeks That Matter for Patients With Gastric Cancer". We conclude with an interview with Dr. Erick Turner of OHSU on the FDA, regulatory capture, selective reporting, and transparency. Elo-pom-dex: <a href="http://doi.org/10.1056/NEJMoa1805762" rel="nofollow" target="_blank">http://doi.org/10.1056/NEJMoa1805762</a> Immunotherapy combinations: <a href="http://doi.org/10.1056/NEJMp1803602" rel="nofollow" target="_blank">http://doi.org/10.1056/NEJMp1803602</a> 9 weeks that matter: <a href="http://doi.org/10.1016/S1470-2045(18)30752-6" rel="nofollow" target="_blank">http://doi.org/10.1016/S1470-2045(18)30752-6</a> Dr. Turner's seminal paper: <a href="https://doi.org/10.1056/NEJMsa065779" rel="nofollow" target="_blank">https://doi.org/10.1056/NEJMsa065779</a>

1.22 Elo-Pom-Dex, Immunotherapy Combos, Inherent Bias, and the FDA with Dr. Erick Turner